Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

36.71
+1.103.09%
Volume:7.34M
Turnover:269.58M
Market Cap:14.16B
PE:-3.96
High:37.55
Open:35.20
Low:35.15
Close:35.61
Loading ...

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

ACCESS Newswire
·
28 Feb

Drug Stocks Are the New Safe Bet in a Shaky Market

Dow Jones
·
28 Feb

1 Healthcare Stock to Own for Decades and 2 to Ignore

StockStory
·
28 Feb

UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older

Reuters
·
28 Feb

UK health regulator approves Moderna's RSV vaccine for people aged 60 and over

Reuters
·
28 Feb

BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over

Reuters
·
28 Feb

Post-Bell|Nasdaq Falls Nearly 3%; Nvidia Slumps 8%; SMCI Tumbles 16%; Tesla Falls 3%; Quantum Computing Stocks Fall, RGTI Drops 13%

Tiger Newspress
·
28 Feb

Moderna Inc. Stock Falls 7.4%, Underperforms Competitors

Dow Jones
·
28 Feb

Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Flu Funds

Blockhead
·
28 Feb

Moderna Shares Fall After Reports of HHS Review of Bird Flu Vaccine Contract -- WSJ

Dow Jones
·
28 Feb

Moderna's stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine award

Dow Jones
·
28 Feb

Stock Track | Moderna Plunges Over 5% in Pre-market as Trump Team Weighs Pulling Bird Flu Vaccine Funding

Stock Track
·
27 Feb

Moderna Shares Down 7.1% After Report Trump Administration Weighs Pulling Funding for Co's Bird Flu Vaccine

THOMSON REUTERS
·
27 Feb

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Moderna, Goldman Sachs

Reuters
·
27 Feb

Stock Track | Moderna Plunges 5% in Pre-market as Trump Administration Weighs Pulling Bird Flu Vaccine Funding

Stock Track
·
27 Feb

Market Chatter: Trump Administration Reviewing Moderna Bird Flu Vaccine Contract Amid Spending Scrutiny

MT Newswires Live
·
27 Feb